A Platform for Partner-Led Botanical Innovation
Every research and development team faces unique formulation challenges, which is why the World Exosome Center platform is not limited to a fixed ingredient catalogue. Partners are actively encouraged to nominate specific botanical sources according to their own research priorities, innovation programs, or product-development strategies.
When a custom botanical source is nominated, AYE Exocure evaluates the technical feasibility of isolating and developing extracellular vesicle preparations from the selected material. This custom development follows a rigorous, nine-step pathway:
Botanical Selection: Partner identifies the source of interest.
Feasibility: Material characteristics and isolation potential are evaluated.
Pilot Isolation: Initial vesicle-enriched fractions are produced.
Characterization: Particle profile, morphology, and relevant analytical parameters are assessed.
Process Development: Isolation and purification parameters are refined.
Stability: Storage and stabilization approaches are evaluated.
Specification: Product-specific quality parameters are established.
Scale-Up: The defined process is transferred toward larger-scale production.
Supply: Material is produced according to the agreed commercial model.
The platform has already successfully processed a diverse featured portfolio, including Coffee Seed, Ginseng Root, Ginkgo Leaf, Ginger Rhizome, and Aloe. Beyond these featured plants, the broader development library extends to materials such as Cannabis sativa (Hemp), Celery Stalk, Milk Thistle, Olive Leaf, St. John's Wort, Viburnum opulus, Turkey Tail Mushroom, Cinnamon Bark, Turmeric Root, Black Grape Seed, and Pomegranate. These scalable preparations open entirely new frontiers for partner-led innovation in cosmetic ingredient research, dermatological research, pharmaceutical research, and cellular communication.
